Business & Economy

On The Money: Trump’s controversial Fed nominee stalled | Economists warn of lag time between vaccine and recovery | Business group calls for national mask mandate, COVID-19 relief

Happy Tuesday and welcome back to On The Money, a Fleet-free zone. I’m Sylvan Lane, and here’s your nightly guide to everything affecting your bills, bank account and bottom line.

See something I missed? Let me know at slane@digital-staging.thehill.com or tweet me @SylvanLane. And if you like your newsletter, you can subscribe to it here: http://bit.ly/1NxxW2N.

Write us with tips, suggestions and news: slane@digital-staging.thehill.com, njagoda@digital-staging.thehill.com and nelis@digital-staging.thehill.com. Follow us on Twitter: @SylvanLane, @NJagoda and @NivElis.

THE BIG DEAL—Trump’s controversial Fed nominee stalled after Senate setback: Judy Shelton’s Federal Reserve Board nomination failed to advance on Tuesday after coronavirus-related quarantines sidelined some Republican senators and Vice President-elect Kamala Harris returned to the upper chamber to provide a crucial “no” vote.

What went wrong for Shelton: The setback comes only days after President Trump’s controversial pick appeared to be on a glide path to be confirmed to the Fed when Sen. Lisa Murkowski (R-Alaska) said she would support her. But two Republicans — Sens. Chuck Grassley (Iowa) and Rick Scott (Fla.) — were quarantined due to exposure to the coronavirus, throwing a late curveball into the Senate’s consideration of her nomination.

The Hill’s Jordain Carney and I tell you more here.

What comes next: Shelton’s nomination isn’t officially doomed, but the narrow window left to confirm her may have closed. 

If the Senate tries to confirm Shelton after Kelly is sworn in, Shelton would need either Kelly to break from all of his new colleagues and vote in favor, or for one of the three Republican senators already opposed to her to change their minds.

LEADING THE DAY

Economists warn of lag time between vaccine and recovery: The U.S. economy could take several more months to benefit from the emergence of successful coronavirus vaccines, putting a renewed focus on the winter as the country faces an unprecedented surge of COVID-19.

Preliminary results from two highly effective vaccine candidates are boosting hopes of a quicker end to the pandemic and a faster recovery from its economic damage. 

But while the light at the end of the tunnel may seem brighter today than it was 10 days ago, economists fear the U.S. still has daunting obstacles in its path.

Economists warn that if the White House and Congress are unable to bridge that gap with further aid, millions of Americans could suffer before the pandemic and economy turn around.

“If they don’t do much more, then we could be looking at a lot more businesses going under, the recovery backtracking and heading in reverse, and a bigger economic hole to dig our way out of,” said Adam Ozimek, chief economist at Upwork.

I explain why here.

Business group calls for national mask mandate, COVID-19 relief: The Business Roundtable, a group of CEOs from major U.S. companies, is calling for a slew of immediate government actions to address the rapidly growing COVID-19 pandemic and its economic consequences, including a national mask mandate and action on a relief bill.

“It’s not as though it’s either safety or economic recovery. There is no economic recovery without safety,” the group’s president, Joshua Bolten, told reporters on Tuesday.

In addition to a national mask mandate, Bolten said the government needs to issue clear safety guidelines for businesses, implement a national testing strategy and reengage with the World Health Organization.

The Hill’s Niv Elis has more here.

GOOD TO KNOW

ODDS AND ENDS